CF-296
/ ContraFect
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 31, 2023
Efficacy of Single and Daily Dose of Lysin CF-296 in Addition to Daptomycin in a Rat Methicillin-Resistant Staphylococcus aureus (MRSA) Osteomyelitis Model
(ASM Microbe 2023)
- "CF-296 administered daily in addition to DAP may be a potential strategy in treating osteomyelitis."
Preclinical • Infectious Disease • Inflammation
1 to 1
Of
1
Go to page
1